The United States Food and Drug Administration (USFDA) has inspected Neuland Laboratories’ Unit 2 manufacturing facility, located at Pashamylaram village, Sangareddy District, in Telangana from April 28, 2025 to May 2, 2025.
The FDA issued Form 483, with one observation related to building and facility management, which the company will respond to within the stipulated timelines.
Neuland Laboratories is a leading manufacturer of active pharmaceutical ingredients (APIs) and an end-to-end solution provider for the pharmaceutical industry’s chemistry needs.
